[Form 4] Arteris, Inc. Insider Trading Activity
Arteris, Inc. director Joachim Kunkel reported receipt of 1,496 shares of common stock as fully vested restricted stock on 10/05/2025.
Rhea-AI Filing Summary
Arteris, Inc. director Joachim Kunkel reported receipt of 1,496 shares of common stock as fully vested restricted stock on 10/05/2025. The shares were issued as retainer fees elected in lieu of cash and the reporting person elected to defer receipt; the transaction price is reported as $0.00.
Following the transaction, the reporting person beneficially owns 67,818 shares. The Form 4 was signed by an attorney-in-fact on 10/06/2025 and indicates the filing is by one reporting person and that the reporting person is a director.
Positive
- None.
Negative
- None.
Insights
Director accepted stock retainer; ownership modestly increased.
The director received 1,496 fully vested restricted shares as a retainer elected in lieu of cash, which increases his direct stake to 67,818 shares. Receiving compensation in equity aligns executive/director pay with shareholder outcomes and removes immediate cash outflow for the company.
This arrangement depends on the board’s compensation policy and share plan limits; the filing notes the reporting person elected to defer receipt, which can affect timing of ownership transfer and potential tax treatment. Monitor subsequent Form 4s for sales or additional grants within the next 12 months.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,496 | $0.00 | $0.00 |
Footnotes (2)
- F1. Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.
- F2. The Reporting Person elected to defer the receipt of shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.